Grace Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,077
| Closed | -$146K | – | 202 |
|
|
2021
Q1 | $146K | Hold |
1,077
| – | – | 0.09% | 167 |
|
|
2020
Q4 | $152K | Sell |
1,077
-181
| -14% | -$25.5K | 0.1% | 169 |
|
|
2020
Q3 | $140K | Sell |
1,258
-5
| -0.4% | -$556 | 0.11% | 149 |
|
|
2020
Q2 | $141K | Buy |
+1,263
| New | +$141K | 0.12% | 139 |
|
|
2019
Q3 | – | Sell |
-18,374
| Closed | -$1.61M | – | 183 |
|
|
2019
Q2 | $1.61M | Sell |
18,374
-1,950
| -10% | -$171K | 0.77% | 39 |
|
|
2019
Q1 | $1.84M | Buy |
+20,324
| New | +$1.84M | 0.72% | 43 |
|